MDS' Short-Term Prospects Rise As NRU Reactor Restart Nears
The Wall Street Journal
Tuesday, July 27, 2010
While MDS Inc.'s (MDZ) long-term isotope-supply issues haven't gone away, things are looking up in the short term.
Analysts say the stock has benefitted recently from the anticipated restart of the aging NRU reactor in Ontario, its chief source of medical isotopes, as well as speculation that a new one-year contract with Lantheus Medical Imaging Inc. for the supply of Molybdenum-99 has the potential for higher-than-average margins. The stock is up about 21% this year, with half that gain coming in the last month.